InvestorsHub Logo
Followers 76
Posts 7150
Boards Moderated 0
Alias Born 10/26/2012

Re: TonyJoe1957 post# 2649

Thursday, 08/13/2020 7:36:57 AM

Thursday, August 13, 2020 7:36:57 AM

Post# of 3011

Cocrystal initiated its preclinical studies of COVID-19 inhibitors received from KSURF during Q2 2020, and further intends to identify additional COVID-19 inhibitors utilizing its proprietary platform technology over the course of the second and third quarter of this year. The Company plans to identify additional inhibitors using its proprietary platform technology in Q3 2020 and anticipates the selection of its lead preclinical molecule in Q4 2020.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COCP News